These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7790625)

  • 1. High-dose intravenous IgG treatment and acute renal failure.
    Veber B; Mohammedi I; Gachot B; Bédos JP; Wolff M
    Intensive Care Med; 1995 Mar; 21(3):288-9. PubMed ID: 7790625
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute renal failure following intravenous immunoglobulin therapy in a HIV-infected patient.
    Metallidis S; Papaioannou M; Bokolas G; Kollaras P; Gogou V; Nikolaidis P
    Clin Nephrol; 2009 Feb; 71(2):196-7. PubMed ID: 19203515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute kidney failure following intravenous administration of high doses of immunoglobulins].
    Cabre P; Smadja D; Odry L; Donikian JC; Vernant JC
    Presse Med; 1994 Jan; 23(3):142. PubMed ID: 8177854
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute renal failure and myocarditis associated with intravenous immunoglobulin therapy.
    Akhtar I; Bastani B
    Ann Intern Med; 2003 Aug; 139(4):W65. PubMed ID: 12966002
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renal complications from intravenous immunoglobulins. Role of renal hemodynamic factors].
    Poullin P; Moulin B; Ollier J; Benaicha M; Olmer M; Gabriel B
    Presse Med; 1995 Mar; 24(9):441-4. PubMed ID: 7746817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute renal failure after intravenous use of immunoglobulin to treat myocarditis].
    Pordeus V; Tostes A; Mesquita CT; Mady C; Mesquita ET
    Arq Bras Cardiol; 2005 Feb; 84(2):167-9. PubMed ID: 15761642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose containing intravenous immunoglobulins. A case-control study.
    Onuigbo MA
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):320-2. PubMed ID: 22238243
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to the commentary by Onuigbo on the article "Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins. A case-control study".
    Moulis G; Sailler L; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):900-1. PubMed ID: 22696169
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute renal failure related to intravenous immunoglobulin infusion in an elderly woman.
    Kwan TH; Tong MK; Siu YP; Leung KT; Lee HK; Yung CY; Au TC
    Hong Kong Med J; 2005 Feb; 11(1):45-9. PubMed ID: 15687516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal failure following immunoglobulin therapy.
    Ahsan N; Wiegand LA; Abendroth CS; Manning EC
    Am J Nephrol; 1996; 16(6):532-6. PubMed ID: 8955767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute kidney injury (AKI) requireing renal replacement therapy in a patient treated with intravenous immunoglobulin].
    Wojtecka A; Kade G; Bilbin-Bukowska A; Niemczyk S
    Pol Merkur Lekarski; 2012 Mar; 32(189):173-5. PubMed ID: 22568183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravenous immunoglobulins and acute renal failure: mechanism and prevention].
    Fakhouri F
    Rev Med Interne; 2007 May; 28 Spec No. 1():4-6. PubMed ID: 17768831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute renal insufficiency and cerebral infarction during high-dose intravenous immunoglobulin therapy].
    Chatot-Henry C; Smadja D; Mehdaoui H; Fournerie P; Drault JN; Brébion A; Sobesky G
    Rev Med Interne; 1998 Dec; 19(12):914-6. PubMed ID: 9887459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy.
    Chacko B; John GT; Balakrishnan N; Kirubakaran MG; Jacob CK
    Ren Fail; 2006; 28(2):193-5. PubMed ID: 16538981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute renal failure resulting from intravenous immunoglobulin therapy.
    Tan E; Hajinazarian M; Bay W; Neff J; Mendell JR
    Arch Neurol; 1993 Feb; 50(2):137-9. PubMed ID: 8431131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renal risks of high-dose intravenous immunoglobulin treatment.
    Stahl M; Schifferli JA
    Nephrol Dial Transplant; 1998 Sep; 13(9):2182-5. PubMed ID: 9761490
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute renal failure after intravenous immunoglobulin therapy.
    Emilie S; Dougados M; Nguyen M; Gossec L
    Clin Exp Rheumatol; 2010; 28(3):444. PubMed ID: 20576233
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute renal failure associated with immunoglobulin administration.
    Michail S; Nakopoulou L; Stavrianopoulos I; Stamatiadis D; Avdikou K; Vaiopoulos G; Stathakis C
    Nephrol Dial Transplant; 1997 Jul; 12(7):1497-9. PubMed ID: 9249797
    [No Abstract]   [Full Text] [Related]  

  • 19. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study.
    Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):314-9. PubMed ID: 21953992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin.
    Tsinalis D; Dickenmann M; Brunner F; Gürke L; Mihatsch M; Nickeleit V
    Am J Kidney Dis; 2002 Sep; 40(3):667-70. PubMed ID: 12200824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.